Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.04. | Modular Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
10.04. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
26.03. | Modular Medical, Inc.: Modular Medical Announces Steve Gemmell as New Vice President of Engineering | 438 | ACCESSWIRE | SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the... ► Artikel lesen | |
04.03. | Modular Medical, Inc.: Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024 | 290 | ACCESSWIRE | Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin... ► Artikel lesen | |
22.02. | Modular Medical closes $10M public offering | 1 | MassDevice | ||
21.02. | Modular Medical, Inc.: Modular Medical Announces Closing of $10 Million Public Offering | 342 | ACCESSWIRE | SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the... ► Artikel lesen | |
16.02. | Modular Medical drops 7%, prices $10M share offering | 2 | Seeking Alpha | ||
16.02. | Modular Medical, Inc.: Modular Medical Announces Pricing of $10 Million Public Offering | 422 | ACCESSWIRE | SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the... ► Artikel lesen | |
15.02. | Modular Medical launches common stock offering | 1 | Investing.com | ||
15.02. | Modular Medical, Inc.: Modular Medical Announces Proposed Public Offering | 289 | ACCESSWIRE | SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical"), a development stage insulin delivery technology company seeking to launch the next generation... ► Artikel lesen | |
15.02. | Modular Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.02. | Modular Medical Inc reports results for the quarter ended in December - Earnings Summary | - | Reuters | ||
05.02. | Modular Medical (MODD) Pairing Technology Issued New U.S. Patent | 1 | Zacks | ||
02.02. | Modular Medical picks up new insulin pump patent for mobile device connectivity | 1 | MassDevice | ||
24.01. | Modular Medical announces issuance of U.S. patent | 1 | Seeking Alpha | ||
24.01. | Modular Medical, Inc.: Modular Medical Announces Issuance of New US Patent | 364 | ACCESSWIRE | SAN DIEGO, CA / ACCESSWIRE / January 24, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the... ► Artikel lesen | |
19.01. | Modular Medical submits next-gen insulin pump for FDA clearance | 1 | MassDevice | ||
19.01. | US STOCKS Intuitive Surgical, Ally Financial, Modular Medical | 10 | Reuters | ||
19.01. | Modular Medical rises after seeking FDA clearance for insulin pump | 1 | Reuters | ||
19.01. | Modular Medical announces 510(k) submission of MODD1 insulin pump | 1 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORPEA | 11,854 | -4,82 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
NANO-X IMAGING | 8,920 | -1,98 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
BUTTERFLY NETWORK | 0,706 | -0,17 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
GOODRX | 7,080 | +1,72 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 12,080 | -1,63 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
CARMAT | 3,150 | -13,93 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
PROGYNY | 32,500 | -0,31 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
HYPERFINE | 0,831 | +2,59 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
MIMEDX | 6,245 | -2,88 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
BIOMERICA | 0,680 | -4,63 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
ATRION | 394,00 | +4,79 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
ATRICURE | 22,610 | -1,91 % | AtriCure upgraded at Oppenheimer on valuation | ||
OUTSET MEDICAL | 2,380 | -6,67 % | FDA labels Outset Medical recall of Tablo hemodialysis system as Class I | ||
AMWELL | 0,541 | +1,88 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
TALKSPACE | 3,080 | +0,33 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen |